DePuy Synthes receives CE Mark for Revive SE device

Medical Company Product News

DePuy Synthes' Codman Neuro division has received European regulatory approval for a next-generation self-expanding clot removal device for the treatment of acute ischaemic stroke.

The Revive SE device is a self-expanding nitinol basket that facilitates navigation through small blood vessels and arteries in the cerebral vasculature, thus enabling rapid restoration of blood flow to the brain during a stroke.

Its closed-ended soft distal tip allows clots and large fragments to be captured with minimal trauma, while the narrow and tall strut design offers better penetration and greater clot engagement.

The Revive SE portfolio is also designed for the non-surgical removal of emboli and thrombi, with aspiration and with the injection or infusion of contrast media and other fluids.

P Laxmin Laxminarain, worldwide president of Codman Neuro, said: "Clinicians told us enhanced navigation was important to them and we have responded with the next-generation Revive SE."

DePuy Synthes is part of the Johnson and Johnson group and was formed last year through the combination of DePuy with the newly-acquired Synthes company.

See all the latest jobs in Medical Devices
Return to news

Tags